Opening the book…
For finished pharmaceuticals, review the applicable sections of 21 CFR Part 211, including 211.180, 211.182, 211.186, 211.188, 211.192, and 211.194. GLP, clinical research, biological products, and devices have additional or different requirements. Always check the scope of a requirement before applying it to a new setting.
FDA may issue Form FDA 483 to communicate inspectional observations. It is not a final agency determination of compliance. A warning letter is a separate action and does not automatically follow every Form 483. Missing, unreliable, or falsified records can be significant findings that require prompt investigation and appropriate corrective action.
ISO 9001 also requires suitable documented information for the QMS and evidence of its operation. The required detail depends on the organization and applicable requirements. ISO 9001 certification concerns the defined management system scope; it is not laboratory accreditation or FDA approval. ISO currently lists ISO 9001:2026. Historical quotations from ISO 9001:2008 should not be presented as the current requirements.

This page titled 13.20: Documentation Requirements and Oversight was last modified on Sun, 08 Nov 2026 21:55:12 GMT and is shared under a CC BY-SA 4.0 license and was authored, remixed, and/or curated by Emalee MacKenzie.
The book could not be loaded just now.